Manufacturer
4 recalls in our database name JB Chemicals and Pharmaceuticals Ltd as the manufacturing or recalling firm.
Of the 4 recalls from JB Chemicals and Pharmaceuticals Ltd we have scored against our rubric, 1 (25%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
JB Chemicals and Pharmaceuticals Ltd is recalling 34,020 bottles of Cetirizine Hydrochloride Tablets USP 5 mg because some tablets were found to contain Ranitidine due to cross contamination.
JB Chemicals and Pharmaceuticals Ltd is recalling Enalapril Maleate 20 mg tablets nationwide due to out-of-specification results in organic impurities testing. Affected lot GEH25023 was distributed nationwide.
JB Chemicals is recalling 9,936 hundred-count bottles of Cetirizine Hydrochloride Tablets USP 10 mg because the tablets were imprinted with the wrong identification code.
JB Chemicals is recalling 13,440 bottles of Cetirizine Hydrochloride Tablets USP 10 mg because the tablets were imprinted with the wrong identification code.